Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
April 24, 2002
[Development of new reverse transcriptase inhibitors]
Eiichi Kodama
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine
|
April 3, 2012
[HIV infection and the mechanism of viral proliferation, with special reference to the stage where the antiviral agents exert their effects]
Eiichi Kodama, Toshio Hattoti
Antiviral Chemistry & Chemotherapy
|
October 28, 2006
A novel colorimetric assay for CXCR4 and CCR5 tropic human immunodeficiency viruses
Keiko Kajiwara, Eiichi Kodama, Masao Matsuoka
Journal of Clinical Microbiology
|
December 21, 2007
Dual-reporter phenotypic assay for human immunodeficiency viruses
Keiko Kajiwara, Eiichi Kodama, Yasuko Sakagami, et al.
The Tohoku Journal of Experimental Medicine
|
June 3, 2026
"Is the Spanish Flu a Forgotten Pandemic?" A Survey during the COVID-19 Pandemic
Yasuhiro Miki, Natsuko Chubachi, Atsushi Kawauchi, et al.
Antiviral Research
|
May 28, 2003
Broad spectrum anti-RNA virus activities of titanium and vanadium substituted polyoxotungstates
Shibro Shigeta, Shuichi Mori, Eiichi Kodama, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
December 11, 2007
2'-deoxy-4'-C-ethynyl-2-fluoroadenosine: a nucleoside reverse transcriptase inhibitor with highly potent activity against wide spectrum of HIV-1 strains, favorable toxic profiles, and stability in plasma
Hiroshi Ohrui, Satoru Kohgo, Hiroyuki Hayakawa, et al.
Nucleic Acids Symposium Series (2004)
|
December 8, 2006
2'-Deoxy-4'-C-ethynyl-2-fluoroadenosine: a nucleoside reverse transcriptase inhibitor with highly potent activity against all HIV-1 strains, favorable toxic profiles and stability in plasma
Hiroshi Ohrui, Satoru Kohgo, Hiroyuki Hayakawa, et al.
The Tohoku Journal of Experimental Medicine
|
July 20, 2022
COVID-19 in a Hairy Cell Leukemia Patient: A Rare Case Report
Hirohito Sano, Koji Murakami, Hisayuki Yokoyama, et al.
Antiviral Chemistry & Chemotherapy
|
October 2, 2004
Potential of 4'-C-substituted nucleosides for the treatment of HIV-1
Hiroyuki Hayakawa, Satoru Kohgo, Kenji Kitano, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
April 24, 2002
[Development of new reverse transcriptase inhibitors]
Eiichi Kodama
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine
|
April 3, 2012
[HIV infection and the mechanism of viral proliferation, with special reference to the stage where the antiviral agents exert their effects]
Eiichi Kodama, Toshio Hattoti
Antiviral Chemistry & Chemotherapy
|
October 28, 2006
A novel colorimetric assay for CXCR4 and CCR5 tropic human immunodeficiency viruses
Keiko Kajiwara, Eiichi Kodama, Masao Matsuoka
Journal of Clinical Microbiology
|
December 21, 2007
Dual-reporter phenotypic assay for human immunodeficiency viruses
Keiko Kajiwara, Eiichi Kodama, Yasuko Sakagami, et al.
The Tohoku Journal of Experimental Medicine
|
June 3, 2026
"Is the Spanish Flu a Forgotten Pandemic?" A Survey during the COVID-19 Pandemic
Yasuhiro Miki, Natsuko Chubachi, Atsushi Kawauchi, et al.
Antiviral Research
|
May 28, 2003
Broad spectrum anti-RNA virus activities of titanium and vanadium substituted polyoxotungstates
Shibro Shigeta, Shuichi Mori, Eiichi Kodama, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
December 11, 2007
2'-deoxy-4'-C-ethynyl-2-fluoroadenosine: a nucleoside reverse transcriptase inhibitor with highly potent activity against wide spectrum of HIV-1 strains, favorable toxic profiles, and stability in plasma
Hiroshi Ohrui, Satoru Kohgo, Hiroyuki Hayakawa, et al.
Nucleic Acids Symposium Series (2004)
|
December 8, 2006
2'-Deoxy-4'-C-ethynyl-2-fluoroadenosine: a nucleoside reverse transcriptase inhibitor with highly potent activity against all HIV-1 strains, favorable toxic profiles and stability in plasma
Hiroshi Ohrui, Satoru Kohgo, Hiroyuki Hayakawa, et al.
The Tohoku Journal of Experimental Medicine
|
July 20, 2022
COVID-19 in a Hairy Cell Leukemia Patient: A Rare Case Report
Hirohito Sano, Koji Murakami, Hisayuki Yokoyama, et al.
Antiviral Chemistry & Chemotherapy
|
October 2, 2004
Potential of 4'-C-substituted nucleosides for the treatment of HIV-1
Hiroyuki Hayakawa, Satoru Kohgo, Kenji Kitano, et al.
Page
of 6